search
Back to results

Transcranial Direct Current Stimulation (tDCS) Combined With Aerobic Exercise in Chronic Nonspecific Low Back Pain (LBP) (tDCS)

Primary Purpose

Low Back Pain, Chronic Low-back Pain

Status
Recruiting
Phase
Not Applicable
Locations
Spain
Study Type
Interventional
Intervention
real tDCS and aerobic exercise
sham tDCS and aerobic exercise
Sponsored by
European University of Madrid
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Low Back Pain focused on measuring low back pain, chronic low back pain, non-specific chronic low back pain, transcranial direct current stimulation, tDCS, aerobic exercise, aerobic training, walking

Eligibility Criteria

18 Years - 65 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria: Diagnosis of non-specific Low Back Pain for at least 3 months based on careful radiological evaluation and clinical diagnosis by a physician. Aged from 18 till 65 years old. Scoring higher than 20mm on the 100 mm VAS scale Scoring higher than 4 on the Rolland-Morris scale Exclusion Criteria: Any subject presenting at least one of the following exclusion criteria will be excluded from the study: Vertebral fractures, osteoporosis Infections Lumbar surgical, herniated disc or nerve root compression Rheumatologic diseases People with central nervous system alterations Structured deformities of the spine (scoliosis) Oncology patients in active treatment or within 5 years after the end of the treatment Fibromyalgia Women who are pregnant or who may be pregnant Contraindications to tDCS (epilepsy, cranial implanted devices, neurological o psychiatric disorders, sever cardiopulmonary, renal or hepatic disorders) Being under physiotherapeutic or osteopathic treatment during the study period Absolute contraindications to aerobic exercise (acute myocardial infarction, unstable angina pectoris, uncontrolled arrhythmia, heart failure, acute pulmonary embolism, myocarditis or acute pericarditis) People who need walking assistance (cane, other person to assist) Patients who practise regular physical activity defined as leisure-time physical activity for 30 minutes, three or more times per week People unable to give informed consent, or unable to complete the selected questionnaires.

Sites / Locations

  • Eurpean University of MadridRecruiting
  • Hospital Universitario Fundación AlcorcónRecruiting

Arms of the Study

Arm 1

Arm 2

Arm 3

Arm Type

Active Comparator

Sham Comparator

Experimental

Arm Label

aerobic exercise

Sham tDCS

real tDCS

Arm Description

Walk on a treadmill during 20-30 minutes at 60-80% of Heart Rate max

Application of tDCS during 30 seconds of 2 mA-intensity.

Application of real tDCS during 20 minutes at 2 mili Amper (mA)-intensity.

Outcomes

Primary Outcome Measures

Pain intensity
Measured with Visual Analogue Scale of 100 mm
Pain intensity
Measured with Visual Analogue Scale of 100 mm
Pain intensity
Measured with Visual Analogue Scale of 100 mm
Pain intensity
Measured with Visual Analogue Scale of 100 mm
Pressure pain
Measured with a pressure algometer
Pressure pain
Measured with a pressure algometer
Pressure pain
Measured with a pressure algometer
Pressure pain
Measured with a pressure algometer

Secondary Outcome Measures

Disability
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Disability
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Disability
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Disability
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Kinesiophobia
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Quality of life questionnaire
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Quality of life questionnaire
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Quality of life questionnaire
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Quality of life questionnaire
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Catastrophism
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Catastrophism
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Catastrophism
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Catastrophism
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Cortical excitation
Measured with Critical Flicker Fusion Threshold
Cortical excitation
Measured with Critical Flicker Fusion Threshold
Cortical excitation
Measured with Critical Flicker Fusion Threshold
Cortical excitation
Measured with Critical Flicker Fusion Threshold
Heart Rate Variability
Measured with Polar Heart Rate belt
Heart Rate Variability
Measured with Polar Heart Rate belt
Heart Rate Variability
Measured with Polar Heart Rate belt
Heart Rate Variability
Measured with Polar Heart Rate belt

Full Information

First Posted
March 31, 2023
Last Updated
September 6, 2023
Sponsor
European University of Madrid
search

1. Study Identification

Unique Protocol Identification Number
NCT05830851
Brief Title
Transcranial Direct Current Stimulation (tDCS) Combined With Aerobic Exercise in Chronic Nonspecific Low Back Pain (LBP)
Acronym
tDCS
Official Title
Transcranial Direct Current Stimulation Combined With Aerobic Exercise for the Treatment of Chronic Nonspecific Low Back Pain: a Randomized Clinical Trial
Study Type
Interventional

2. Study Status

Record Verification Date
September 2023
Overall Recruitment Status
Recruiting
Study Start Date
November 17, 2023 (Anticipated)
Primary Completion Date
July 2024 (Anticipated)
Study Completion Date
August 2024 (Anticipated)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
European University of Madrid

4. Oversight

Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No

5. Study Description

Brief Summary
The goal of this clinical trial is to learn about the effects of transcranial direct current stimulation (tDCS) combined with aerobic exercise in non-specific low back pain patients. The main question aims to answer: • Which are the effects of tDCS treatment combined with aerobic exercise compared to Sham tDCS combined with aerobic exercise in non-specific Low Back Pain? Participants will be asked to complete questionnaires and they will receive treatments as tDCS or Sham tDCS and aerobic exercise (treadmill walking). Researchers will compare a group who is treated with a combination of tDCS and aerobic exercise versus a group receiving placebo tDCS and aerobic exercise to see the effects on pain intensity, pressure pain, disability, kinesiophobia, quality of life, catastrophism, Heart Rate Variability and cortical excitation.
Detailed Description
Low back pain (LBP) is the main cause of disability worldwide with a prevalence of 70 to 85% of the population. Chronic LBP (CLBP) is defined as a pain lasting more than 12 weeks. CLBP does not have peripheral nociceptive stimuli, but it is characterized by the presence of a chronic change in neuroplasticity. Transcranial direct current stimulation (tDCS) is a type of therapeutic intervention that can modulate the cortical excitability of a wide neural network involved in the elaboration of pain, resulting in an efficacy option for CLBP treatment. Aerobic exercise represents another typology of effective therapeutic intervention in the treatment of pain intensity and disability related to CLBP. The main objective of the study is to determine the efficacy of tDCS combined with aerobic exercise compared to shame/placebo tDCS combined with aerobic exercise in middle-aged subjects with non-specific CLBP in the short, medium and long term. Methods: In a double-blinded pilot randomized controlled trial, 38 subjects aged between 18 and 65 years, with a diagnose of non-specific LBP for 3 months, a Visual Analogue Scale (VAS) result of >20mm and a Roland-Morris Scale result of >4 will be selected for the following study. Participants will be divided in two groups of 19 subjects each one: experimental group A (20 minutes of tDCS at 2 mili Amper + 20-30 minutes of aerobic exercise at 60-80% of HRmax) and controlled group B (30 seconds of sham/placebo tDCS at 2milli amperes + 20-30 minutes of aerobic exercise at 60-80% of maximum heart rate). The following outcomes will be measured: pain intensity (100mm VAS), pressure pain (pressure algometer), disability (Roland-Morris questionnaire), kinesiophobia (Tampa Scale for kinesiophobia), quality of life (SF-12 health questionnaire), catastrophism (Pain Catastrophizing Scale), Heart Rate Variability ( Polar Team) and cortical excitation (Critical Flicker Fusion).

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Low Back Pain, Chronic Low-back Pain
Keywords
low back pain, chronic low back pain, non-specific chronic low back pain, transcranial direct current stimulation, tDCS, aerobic exercise, aerobic training, walking

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantCare ProviderOutcomes Assessor
Allocation
Randomized
Enrollment
38 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
aerobic exercise
Arm Type
Active Comparator
Arm Description
Walk on a treadmill during 20-30 minutes at 60-80% of Heart Rate max
Arm Title
Sham tDCS
Arm Type
Sham Comparator
Arm Description
Application of tDCS during 30 seconds of 2 mA-intensity.
Arm Title
real tDCS
Arm Type
Experimental
Arm Description
Application of real tDCS during 20 minutes at 2 mili Amper (mA)-intensity.
Intervention Type
Other
Intervention Name(s)
real tDCS and aerobic exercise
Intervention Description
Walking on a treadmill at 60-80% of HRmax while wearing a head tDCS device with therapeutic parameters
Intervention Type
Other
Intervention Name(s)
sham tDCS and aerobic exercise
Intervention Description
Walking on a treadmill at 60-80% of HRmax while wearing a head tDCS device with sham tDCS
Primary Outcome Measure Information:
Title
Pain intensity
Description
Measured with Visual Analogue Scale of 100 mm
Time Frame
At baseline
Title
Pain intensity
Description
Measured with Visual Analogue Scale of 100 mm
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions).
Title
Pain intensity
Description
Measured with Visual Analogue Scale of 100 mm
Time Frame
Follow-up at the third month after treatment completion
Title
Pain intensity
Description
Measured with Visual Analogue Scale of 100 mm
Time Frame
Follow-up at the sixth month after treatment completion
Title
Pressure pain
Description
Measured with a pressure algometer
Time Frame
At baseline
Title
Pressure pain
Description
Measured with a pressure algometer
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions).
Title
Pressure pain
Description
Measured with a pressure algometer
Time Frame
Follow-up at the third month after treatment completion
Title
Pressure pain
Description
Measured with a pressure algometer
Time Frame
Follow-up at the sixth month after treatment completion
Secondary Outcome Measure Information:
Title
Disability
Description
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Time Frame
At baseline
Title
Disability
Description
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions).
Title
Disability
Description
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Time Frame
Follow-up at the third month after treatment completion
Title
Disability
Description
Measured with Roland-Morris scale Spanish version, minimum and maximum values go from 0 (absence of disability) until 24 (maximum disability)
Time Frame
Follow-up at the sixth month after treatment completion
Title
Kinesiophobia
Description
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time Frame
At baseline
Title
Kinesiophobia
Description
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions)
Title
Kinesiophobia
Description
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time Frame
Follow-up at the third month after treatment completion
Title
Kinesiophobia
Description
Measured with Tampa Kinesiophobia Scale questionnaire (TSK-11SV) Spanish version. Minimum and maximum values are between 11 and 44 point, a result with higher values indicates higher level of kinesiofobia.
Time Frame
Follow-up at the sixth month after treatment completion
Title
Quality of life questionnaire
Description
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Time Frame
Al baseline
Title
Quality of life questionnaire
Description
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions)
Title
Quality of life questionnaire
Description
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Time Frame
Follow-up at the third month after treatment completion
Title
Quality of life questionnaire
Description
Measured with SF-12 Health Questionnaire Spanish version. A zero score indicates the lowest level of dimension measured by the scale, and 100 indicates the highest level of the measured dimension
Time Frame
Follow-up at the sixth month after treatment completion
Title
Catastrophism
Description
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Time Frame
At baseline
Title
Catastrophism
Description
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions)
Title
Catastrophism
Description
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Time Frame
Follow-up at the third month after treatment completion
Title
Catastrophism
Description
Measured with Pain Catastrophism Scale Spanish version. The total score ranges from 0 to 52. Higher scores reflect higher levels of catastrophic thinking.
Time Frame
Follow-up at the sixth month after treatment completion
Title
Cortical excitation
Description
Measured with Critical Flicker Fusion Threshold
Time Frame
At baseline
Title
Cortical excitation
Description
Measured with Critical Flicker Fusion Threshold
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions)
Title
Cortical excitation
Description
Measured with Critical Flicker Fusion Threshold
Time Frame
Follow-up at the third month after treatment completion
Title
Cortical excitation
Description
Measured with Critical Flicker Fusion Threshold
Time Frame
Follow-up at the sixth month after treatment completion
Title
Heart Rate Variability
Description
Measured with Polar Heart Rate belt
Time Frame
At baseline
Title
Heart Rate Variability
Description
Measured with Polar Heart Rate belt
Time Frame
At the first month after intervention onset (after completion of the 12 treatment sessions)
Title
Heart Rate Variability
Description
Measured with Polar Heart Rate belt
Time Frame
Follow-up at the third month after treatment completion
Title
Heart Rate Variability
Description
Measured with Polar Heart Rate belt
Time Frame
Follow-up at the sixth month after treatment completion

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
65 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of non-specific Low Back Pain for at least 3 months based on careful radiological evaluation and clinical diagnosis by a physician. Aged from 18 till 65 years old. Scoring higher than 20mm on the 100 mm VAS scale Scoring higher than 4 on the Rolland-Morris scale Exclusion Criteria: Any subject presenting at least one of the following exclusion criteria will be excluded from the study: Vertebral fractures, osteoporosis Infections Lumbar surgical, herniated disc or nerve root compression Rheumatologic diseases People with central nervous system alterations Structured deformities of the spine (scoliosis) Oncology patients in active treatment or within 5 years after the end of the treatment Fibromyalgia Women who are pregnant or who may be pregnant Contraindications to tDCS (epilepsy, cranial implanted devices, neurological o psychiatric disorders, sever cardiopulmonary, renal or hepatic disorders) Being under physiotherapeutic or osteopathic treatment during the study period Absolute contraindications to aerobic exercise (acute myocardial infarction, unstable angina pectoris, uncontrolled arrhythmia, heart failure, acute pulmonary embolism, myocarditis or acute pericarditis) People who need walking assistance (cane, other person to assist) Patients who practise regular physical activity defined as leisure-time physical activity for 30 minutes, three or more times per week People unable to give informed consent, or unable to complete the selected questionnaires.
Central Contact Person:
First Name & Middle Initial & Last Name or Official Title & Degree
Marina Castel- Sánchez, PhD
Phone
0034-679448994
Email
marina.castel@universidadeuropea.es
First Name & Middle Initial & Last Name or Official Title & Degree
Dolores Sosa- Reina, PhD
Phone
0034628432666
Email
mariadolores.sosa@universidadeuropea.es
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Marina Castel Sánchez, PhD
Organizational Affiliation
European University of Madrid.Department of Physiotherapy, Chiropody and Dance
Official's Role
Principal Investigator
Facility Information:
Facility Name
Eurpean University of Madrid
City
Villaviciosa De Odón
State/Province
Madrid
ZIP/Postal Code
28670
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Marina Castel Sanchez, PhD
Phone
0034679448
Email
marina.castel@universidadeuropea.es
First Name & Middle Initial & Last Name & Degree
Dolores Sosa Reina, PhD
Phone
0034628432666
Email
mariadolores.sosa@universidadeuropea.es
Facility Name
Hospital Universitario Fundación Alcorcón
City
Alcorcón
Country
Spain
Individual Site Status
Recruiting
Facility Contact:
First Name & Middle Initial & Last Name & Degree
Alvaro Lopez Hualda

12. IPD Sharing Statement

Plan to Share IPD
No
Citations:
PubMed Identifier
32647923
Citation
Alwardat M, Pisani A, Etoom M, Carpenedo R, Chine E, Dauri M, Leonardis F, Natoli S. Is transcranial direct current stimulation (tDCS) effective for chronic low back pain? A systematic review and meta-analysis. J Neural Transm (Vienna). 2020 Sep;127(9):1257-1270. doi: 10.1007/s00702-020-02223-w. Epub 2020 Jul 9.
Results Reference
background
PubMed Identifier
34450274
Citation
Wong CK, Mak RY, Kwok TS, Tsang JS, Leung MY, Funabashi M, Macedo LG, Dennett L, Wong AY. Prevalence, Incidence, and Factors Associated With Non-Specific Chronic Low Back Pain in Community-Dwelling Older Adults Aged 60 Years and Older: A Systematic Review and Meta-Analysis. J Pain. 2022 Apr;23(4):509-534. doi: 10.1016/j.jpain.2021.07.012. Epub 2021 Aug 24.
Results Reference
background
PubMed Identifier
32006236
Citation
Pergolizzi JV Jr, LeQuang JA. Rehabilitation for Low Back Pain: A Narrative Review for Managing Pain and Improving Function in Acute and Chronic Conditions. Pain Ther. 2020 Jun;9(1):83-96. doi: 10.1007/s40122-020-00149-5. Epub 2020 Jan 31.
Results Reference
background
PubMed Identifier
32111675
Citation
Tornero Aguilera JF, Fernandez Elias V, Clemente-Suarez VJ. Autonomic and cortical response of soldiers in different combat scenarios. BMJ Mil Health. 2021 Jun;167(3):172-176. doi: 10.1136/jramc-2019-001285. Epub 2020 Feb 27.
Results Reference
background
PubMed Identifier
32526017
Citation
Cavalcante PGL, Baptista AF, Cardoso VS, Filgueiras MC, Hasue RH, Joao SMA, Hazime FA. Transcranial Direct Current Stimulation Combined With Therapeutic Exercise in Chronic Low Back Pain: Protocol of a Randomized Controlled Trial. Phys Ther. 2020 Aug 31;100(9):1595-1602. doi: 10.1093/ptj/pzaa105.
Results Reference
background
PubMed Identifier
28827229
Citation
Ouellette AL, Liston MB, Chang WJ, Walton DM, Wand BM, Schabrun SM. Safety and feasibility of transcranial direct current stimulation (tDCS) combined with sensorimotor retraining in chronic low back pain: a protocol for a pilot randomised controlled trial. BMJ Open. 2017 Aug 21;7(8):e013080. doi: 10.1136/bmjopen-2016-013080.
Results Reference
background
PubMed Identifier
29952860
Citation
Pinto CB, Teixeira Costa B, Duarte D, Fregni F. Transcranial Direct Current Stimulation as a Therapeutic Tool for Chronic Pain. J ECT. 2018 Sep;34(3):e36-e50. doi: 10.1097/YCT.0000000000000518.
Results Reference
background
PubMed Identifier
26903788
Citation
DosSantos MF, Ferreira N, Toback RL, Carvalho AC, DaSilva AF. Potential Mechanisms Supporting the Value of Motor Cortex Stimulation to Treat Chronic Pain Syndromes. Front Neurosci. 2016 Feb 11;10:18. doi: 10.3389/fnins.2016.00018. eCollection 2016.
Results Reference
background
PubMed Identifier
32845195
Citation
Pacheco-Barrios K, Cardenas-Rojas A, Thibaut A, Costa B, Ferreira I, Caumo W, Fregni F. Methods and strategies of tDCS for the treatment of pain: current status and future directions. Expert Rev Med Devices. 2020 Sep;17(9):879-898. doi: 10.1080/17434440.2020.1816168. Epub 2020 Sep 15.
Results Reference
background
PubMed Identifier
32569082
Citation
Bruehl S, Burns JW, Koltyn K, Gupta R, Buvanendran A, Edwards D, Chont M, Wu YH, Qu'd D, Stone A. Are endogenous opioid mechanisms involved in the effects of aerobic exercise training on chronic low back pain? A randomized controlled trial. Pain. 2020 Dec;161(12):2887-2897. doi: 10.1097/j.pain.0000000000001969.
Results Reference
background
PubMed Identifier
25529265
Citation
O'Connor SR, Tully MA, Ryan B, Bleakley CM, Baxter GD, Bradley JM, McDonough SM. Walking exercise for chronic musculoskeletal pain: systematic review and meta-analysis. Arch Phys Med Rehabil. 2015 Apr;96(4):724-734.e3. doi: 10.1016/j.apmr.2014.12.003. Epub 2014 Dec 19. Erratum In: Arch Phys Med Rehabil. 2015 Jun;96(6):1182.
Results Reference
background

Learn more about this trial

Transcranial Direct Current Stimulation (tDCS) Combined With Aerobic Exercise in Chronic Nonspecific Low Back Pain (LBP)

We'll reach out to this number within 24 hrs